Listing 13.05
Lymphoma (including mycosis fungoides, but excluding T-cell lymphoblastic lymphoma—13.06)
This listing covers lymphomas, which are cancers of the lymph system, including non-Hodgkin lymphoma, Hodgkin lymphoma, mycosis fungoides, and mantle cell lymphoma.
Read the full plain-language explanation
T-cell lymphoblastic lymphoma is evaluated under the leukemia listing instead. SSA looks for lymphoma that did not respond to treatment, came back, needed multiple treatment regimens within a year, was treated with a bone marrow or stem cell transplant, or is mantle cell type. Only one path (A, B, C, or D) is needed.
Upload your medical records
PDFs or photos (JPG, PNG) — up to 15 files, 20 MB each.
What Listing 13.05 asks for
What SSA looks for — see the 5 items
We will check your records against each of these. Every item comes straight from SSA's own listing.
- You have a fast-growing (aggressive) non-Hodgkin lymphoma, such as diffuse large B-cell lymphoma, that is still present after your first course of treatment or came back afterward.
- This alone is enough.
Read the original wording
You have a fast-growing (aggressive) non-Hodgkin lymphoma, such as diffuse large B-cell lymphoma, that is still present after your first course of treatment or came back afterward. This alone is enough.
(Listing 13.05, criterion A1)
- You have a slow-growing (indolent) lymphoma that needed more than one full treatment regimen started within 12 months because the first one did not keep the disease stable.
- A treatment change made just because you or your doctor preferred a different treatment does not count.
- This alone is enough.
Read the original wording
You have a slow-growing (indolent) lymphoma that needed more than one full treatment regimen started within 12 months because the first one did not keep the disease stable. A treatment change made just because you or your doctor preferred a different treatment does not count. This alone is enough.
(Listing 13.05, criterion A2)
- You have Hodgkin lymphoma that never fully went away with treatment, or it came back within 12 months of finishing the first course of treatment.
- Note: Hodgkin lymphoma that comes back more than 12 months after treatment is considered a new disease, not a recurrence.
- This alone is enough.
Read the original wording
You have Hodgkin lymphoma that never fully went away with treatment, or it came back within 12 months of finishing the first course of treatment. Note: Hodgkin lymphoma that comes back more than 12 months after treatment is considered a new disease, not a recurrence. This alone is enough.
(Listing 13.05, criterion B)
- You had a bone marrow or stem cell transplant to treat the lymphoma.
- SSA considers you disabled for at least 12 months from the transplant date.
- The transplant must have actually happened, not just be planned.
- This alone is enough.
Read the original wording
You had a bone marrow or stem cell transplant to treat the lymphoma. SSA considers you disabled for at least 12 months from the transplant date. The transplant must have actually happened, not just be planned. This alone is enough.
(Listing 13.05, criterion C)
You have mantle cell lymphoma. The diagnosis itself is enough — no treatment failure or spread needs to be shown.
(Listing 13.05, criterion D)
How long it must last:
- Criterion C: considered disabling until at least 12 months from the date of transplantation.
- Criterion A2: considered disabling from at least the date the failed treatment regimen started.
- Otherwise, under 13.00H2, disabling until at least 3 years after onset of complete remission.
Read the original wording
Criterion C: considered disabling until at least 12 months from the date of transplantation. Criterion A2: considered disabling from at least the date the failed treatment regimen started. Otherwise, under 13.00H2, disabling until at least 3 years after onset of complete remission.